Keyphrases
Colorectal Cancer
100%
Trifluridine-tipiracil
100%
Fixed Combination
100%
Tipiracil
100%
TAS-102
100%
Metastatic Colorectal Cancer (mCRC)
75%
Novel Combinations
50%
New Drugs
25%
Area Cover
25%
Unmet Needs
25%
Resistance Mechanisms
25%
Expert Opinion
25%
Clinical Data
25%
Biomarkers of Response
25%
Potential Identification
25%
Overall Survival
25%
Potential Biomarkers
25%
Tolerability
25%
Toxicity Profile
25%
Advanced Colorectal Cancer
25%
Survival Benefit
25%
Clinical Investigation
25%
Fluoropyrimidine
25%
Pharmacological Data
25%
Primary Resistance
25%
Armamentarium
25%
Molecular Oncology
25%
Trifluridine
25%
Secondary Resistance
25%
Colorectal Cancer Prognosis
25%
Refractory Colorectal Cancer
25%
Pharmacology, Toxicology and Pharmaceutical Science
Metastatic Colorectal Cancer
100%
Trifluridine
100%
Tipiracil
100%
Colorectal Carcinoma
100%
Clinical Study
33%
Tolerability
33%
Biological Marker
33%
Cancer Prognosis
33%
Overall Survival
33%
Fluoropyrimidine
33%